Literature DB >> 2740212

Regulation of expression of the c-sis proto-oncogene.

L Ratner1.   

Abstract

Regulation of expression of platelet derived growth factor polypeptide B encoded by the c-sis proto-oncogene is important in a number of physiological and pathological conditions. Sequences in the 1028 nucleotide long 5' untranslated region of the c-sis mRNA were found to inhibit protein synthesis. The inhibition is relieved by deletion of nucleotides 154-378 or 398-475. Sequences within 375 nucleotides upstream of the RNA initiation site are important for transcriptional activity. Sequences in two portions of this region, between -375 and -235 nucleotides and between -235 and -99 nucleotides relative to the RNA CAP site are important for full activity. A transcriptional enhancer activity is demonstrated by its ability to increase the activity of the human T lymphotropic virus type (HTLV) I promoter at a distance and in an orientation-independent manner. Furthermore, sequences upstream of the c-sis RNA CAP site respond to the HTLV I transactivator protein to increase RNA synthesis from either the c-sis or HTLV I promoter.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2740212      PMCID: PMC317922          DOI: 10.1093/nar/17.11.4101

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  108 in total

1.  Isolation and sequencing of a cDNA clone homologous to the v-sis oncogene from human endothelial cells.

Authors:  B D Tong; S E Levine; M Jaye; G Ricca; W Drohan; T Maciag; T F Deuel
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

2.  Bifunctional messenger RNAs in eukaryotes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

3.  Epidemiological parameters of HIV transmission.

Authors:  R M Anderson; R M May
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

Review 4.  Oncogenes: their role in neoplastic transformation.

Authors:  L Ratner; S F Josephs; F Wong-Staal
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

5.  Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class.

Authors:  R G Gronwald; F J Grant; B A Haldeman; C E Hart; P J O'Hara; F S Hagen; R Ross; D F Bowen-Pope; M J Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Two classes of PDGF receptor recognize different isoforms of PDGF.

Authors:  C E Hart; J W Forstrom; J D Kelly; R A Seifert; R A Smith; R Ross; M J Murray; D F Bowen-Pope
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

7.  Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription.

Authors:  K Shimotohno; M Takano; T Teruuchi; M Miwa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  Phorbol ester induces c-sis gene transcription in stem cell line K-562.

Authors:  O R Colamonici; J B Trepel; C A Vidal; L M Neckers
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

9.  Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation.

Authors:  J L Casey; M W Hentze; D M Koeller; S W Caughman; T A Rouault; R D Klausner; J B Harford
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

10.  Structure of the human interleukin-2 receptor gene.

Authors:  W J Leonard; J M Depper; M Kanehisa; M Krönke; N J Peffer; P B Svetlik; M Sullivan; W C Greene
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

View more
  14 in total

1.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization.

Authors:  J T Kimata; L Ratner
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes.

Authors:  T Yamagata; J Nishida; S Tanaka; R Sakai; K Mitani; M Yoshida; T Taniguchi; Y Yazaki; H Hirai
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 4.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

5.  Determination of the c-MYC DNA-binding site.

Authors:  T D Halazonetis; A N Kandil
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

6.  Transactivation of human T-cell leukemia virus type 1 by herpes simplex virus type 1.

Authors:  S Israel; M Mendelovitz; A Honigman
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

7.  Two preproendothelin 1 mRNAs transcribed by alternative promoters.

Authors:  L Benatti; L Bonecchi; L Cozzi; P Sarmientos
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression.

Authors:  F Kashanchi; J F Duvall; P F Lindholm; M F Radonovich; J N Brady
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation.

Authors:  E Suzuki; K Guo; M Kolman; Y T Yu; K Walsh
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated region.

Authors:  B A Arrick; A L Lee; R L Grendell; R Derynck
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.